Psychologist Ralph Hood’s study of serpent handling and mysticism helped legitimize the study of psychedelics. So why doesn't he want them approved for...
The article Microdose Brings Psychedelics to the Concordia Summit was originally published on Microdose. While Davos and the World Economic Forum get...
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday that the previously released positive topline data The post MindMed...
The article MindMed Faces Tough IP Questions (and Publishes Positive Trial Results) was originally published on Microdose. MindMed’s been in the news...
Source: chuyuss / Shutterstock.com Some solar stocks are on the move Thursday thanks to a few different catalysts worth looking into. First off we have...
Source: shutterstock.com/T. Schneider ShiftPixy (NASDAQ:PIXY) stock is rocketing higher on Thursday after the company announced plans to spin off ShiftPixy...
Source: Daniel Patrick Martin / Shutterstock.com MindMed (NASDAQ:MNMD) stock is on the move Wednesday following positive data from a Phase II clinical...
The article The Medicalization of Sacred Plant Medicines was originally published on Microdose. Like many, I’ve watched the recent resurgence of interest...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD | NEO: MMED), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders,...
The article A Deeper Look at Ketamine for Alcohol Use Disorder was originally published on Microdose. In the last decades, there has been a growing interest...